ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Infectious Bursal Disease Vaccine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-28K6459
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Infectious Bursal Disease Vaccine Market Insights Forecast to 2028
BUY CHAPTERS

Global Infectious Bursal Disease Vaccine Market Research Report 2025

Code: QYRE-Auto-28K6459
Report
July 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Zoetis Inc
Merck
Elanco
Boehringer Ingelheim
Ceva
Qingdao Yibang Biological Engineering Co., Ltd.
Shandong Lvdu Biological Technology Co., Ltd.
Plyco Bioengineering Co., Ltd.
Ruipu Biopharmaceutical Co., Ltd.
Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.

Infectious Bursal Disease Vaccine Market

The global market for Infectious Bursal Disease Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Infectious Bursal Disease Vaccine is used to prevent infectious bursal disease in chickens, which is one of the main infectious diseases in the chicken industry.
North American market for Infectious Bursal Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Infectious Bursal Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Infectious Bursal Disease Vaccine include Zoetis, Merck, Elanco, Boehringer Ingelheim, Ceva, Qingdao Yibang Biological Engineering Co., Ltd., Shandong Lvdu Biological Technology Co., Ltd., Plyco Bioengineering Co., Ltd., Ruipu Biopharmaceutical Co., Ltd., Harbin Pharmaceutical Group Biological Vaccine Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Infectious Bursal Disease Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Bursal Disease Vaccine.
The Infectious Bursal Disease Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Infectious Bursal Disease Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infectious Bursal Disease Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Infectious Bursal Disease Vaccine Market Report

Report Metric Details
Report Name Infectious Bursal Disease Vaccine Market
Segment by Type
  • Live
  • Inactivated
Segment by Application
  • Veterinary Pharmacy
  • Online Sale
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Zoetis, Merck, Elanco, Boehringer Ingelheim, Ceva, Qingdao Yibang Biological Engineering Co., Ltd., Shandong Lvdu Biological Technology Co., Ltd., Plyco Bioengineering Co., Ltd., Ruipu Biopharmaceutical Co., Ltd., Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Infectious Bursal Disease Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Infectious Bursal Disease Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Infectious Bursal Disease Vaccine Market report?

Ans: The main players in the Infectious Bursal Disease Vaccine Market are Zoetis, Merck, Elanco, Boehringer Ingelheim, Ceva, Qingdao Yibang Biological Engineering Co., Ltd., Shandong Lvdu Biological Technology Co., Ltd., Plyco Bioengineering Co., Ltd., Ruipu Biopharmaceutical Co., Ltd., Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.

What are the Application segmentation covered in the Infectious Bursal Disease Vaccine Market report?

Ans: The Applications covered in the Infectious Bursal Disease Vaccine Market report are Veterinary Pharmacy, Online Sale, Others

What are the Type segmentation covered in the Infectious Bursal Disease Vaccine Market report?

Ans: The Types covered in the Infectious Bursal Disease Vaccine Market report are Live, Inactivated

1 Infectious Bursal Disease Vaccine Market Overview
1.1 Product Definition
1.2 Infectious Bursal Disease Vaccine by Type
1.2.1 Global Infectious Bursal Disease Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Live
1.2.3 Inactivated
1.3 Infectious Bursal Disease Vaccine by Application
1.3.1 Global Infectious Bursal Disease Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Veterinary Pharmacy
1.3.3 Online Sale
1.3.4 Others
1.4 Global Infectious Bursal Disease Vaccine Market Size Estimates and Forecasts
1.4.1 Global Infectious Bursal Disease Vaccine Revenue 2020-2031
1.4.2 Global Infectious Bursal Disease Vaccine Sales 2020-2031
1.4.3 Global Infectious Bursal Disease Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Infectious Bursal Disease Vaccine Market Competition by Manufacturers
2.1 Global Infectious Bursal Disease Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Infectious Bursal Disease Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Infectious Bursal Disease Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Infectious Bursal Disease Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Infectious Bursal Disease Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Infectious Bursal Disease Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Infectious Bursal Disease Vaccine, Date of Enter into This Industry
2.8 Global Infectious Bursal Disease Vaccine Market Competitive Situation and Trends
2.8.1 Global Infectious Bursal Disease Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Infectious Bursal Disease Vaccine Players Market Share by Revenue
2.8.3 Global Infectious Bursal Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Infectious Bursal Disease Vaccine Market Scenario by Region
3.1 Global Infectious Bursal Disease Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Infectious Bursal Disease Vaccine Sales by Region: 2020-2031
3.2.1 Global Infectious Bursal Disease Vaccine Sales by Region: 2020-2025
3.2.2 Global Infectious Bursal Disease Vaccine Sales by Region: 2026-2031
3.3 Global Infectious Bursal Disease Vaccine Revenue by Region: 2020-2031
3.3.1 Global Infectious Bursal Disease Vaccine Revenue by Region: 2020-2025
3.3.2 Global Infectious Bursal Disease Vaccine Revenue by Region: 2026-2031
3.4 North America Infectious Bursal Disease Vaccine Market Facts & Figures by Country
3.4.1 North America Infectious Bursal Disease Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Infectious Bursal Disease Vaccine Sales by Country (2020-2031)
3.4.3 North America Infectious Bursal Disease Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Infectious Bursal Disease Vaccine Market Facts & Figures by Country
3.5.1 Europe Infectious Bursal Disease Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Infectious Bursal Disease Vaccine Sales by Country (2020-2031)
3.5.3 Europe Infectious Bursal Disease Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Infectious Bursal Disease Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Infectious Bursal Disease Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Infectious Bursal Disease Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Infectious Bursal Disease Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Infectious Bursal Disease Vaccine Market Facts & Figures by Country
3.7.1 Latin America Infectious Bursal Disease Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Infectious Bursal Disease Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Infectious Bursal Disease Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Infectious Bursal Disease Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Infectious Bursal Disease Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Infectious Bursal Disease Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Infectious Bursal Disease Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Infectious Bursal Disease Vaccine Sales by Type (2020-2031)
4.1.1 Global Infectious Bursal Disease Vaccine Sales by Type (2020-2025)
4.1.2 Global Infectious Bursal Disease Vaccine Sales by Type (2026-2031)
4.1.3 Global Infectious Bursal Disease Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Infectious Bursal Disease Vaccine Revenue by Type (2020-2031)
4.2.1 Global Infectious Bursal Disease Vaccine Revenue by Type (2020-2025)
4.2.2 Global Infectious Bursal Disease Vaccine Revenue by Type (2026-2031)
4.2.3 Global Infectious Bursal Disease Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Infectious Bursal Disease Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Infectious Bursal Disease Vaccine Sales by Application (2020-2031)
5.1.1 Global Infectious Bursal Disease Vaccine Sales by Application (2020-2025)
5.1.2 Global Infectious Bursal Disease Vaccine Sales by Application (2026-2031)
5.1.3 Global Infectious Bursal Disease Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Infectious Bursal Disease Vaccine Revenue by Application (2020-2031)
5.2.1 Global Infectious Bursal Disease Vaccine Revenue by Application (2020-2025)
5.2.2 Global Infectious Bursal Disease Vaccine Revenue by Application (2026-2031)
5.2.3 Global Infectious Bursal Disease Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Infectious Bursal Disease Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Company Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Zoetis Infectious Bursal Disease Vaccine Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck Infectious Bursal Disease Vaccine Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Elanco
6.3.1 Elanco Company Information
6.3.2 Elanco Description and Business Overview
6.3.3 Elanco Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Elanco Infectious Bursal Disease Vaccine Product Portfolio
6.3.5 Elanco Recent Developments/Updates
6.4 Boehringer Ingelheim
6.4.1 Boehringer Ingelheim Company Information
6.4.2 Boehringer Ingelheim Description and Business Overview
6.4.3 Boehringer Ingelheim Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Boehringer Ingelheim Infectious Bursal Disease Vaccine Product Portfolio
6.4.5 Boehringer Ingelheim Recent Developments/Updates
6.5 Ceva
6.5.1 Ceva Company Information
6.5.2 Ceva Description and Business Overview
6.5.3 Ceva Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Ceva Infectious Bursal Disease Vaccine Product Portfolio
6.5.5 Ceva Recent Developments/Updates
6.6 Qingdao Yibang Biological Engineering Co., Ltd.
6.6.1 Qingdao Yibang Biological Engineering Co., Ltd. Company Information
6.6.2 Qingdao Yibang Biological Engineering Co., Ltd. Description and Business Overview
6.6.3 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio
6.6.5 Qingdao Yibang Biological Engineering Co., Ltd. Recent Developments/Updates
6.7 Shandong Lvdu Biological Technology Co., Ltd.
6.7.1 Shandong Lvdu Biological Technology Co., Ltd. Company Information
6.7.2 Shandong Lvdu Biological Technology Co., Ltd. Description and Business Overview
6.7.3 Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio
6.7.5 Shandong Lvdu Biological Technology Co., Ltd. Recent Developments/Updates
6.8 Plyco Bioengineering Co., Ltd.
6.8.1 Plyco Bioengineering Co., Ltd. Company Information
6.8.2 Plyco Bioengineering Co., Ltd. Description and Business Overview
6.8.3 Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio
6.8.5 Plyco Bioengineering Co., Ltd. Recent Developments/Updates
6.9 Ruipu Biopharmaceutical Co., Ltd.
6.9.1 Ruipu Biopharmaceutical Co., Ltd. Company Information
6.9.2 Ruipu Biopharmaceutical Co., Ltd. Description and Business Overview
6.9.3 Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio
6.9.5 Ruipu Biopharmaceutical Co., Ltd. Recent Developments/Updates
6.10 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
6.10.1 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Company Information
6.10.2 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Description and Business Overview
6.10.3 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio
6.10.5 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Infectious Bursal Disease Vaccine Industry Chain Analysis
7.2 Infectious Bursal Disease Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Infectious Bursal Disease Vaccine Production Mode & Process Analysis
7.4 Infectious Bursal Disease Vaccine Sales and Marketing
7.4.1 Infectious Bursal Disease Vaccine Sales Channels
7.4.2 Infectious Bursal Disease Vaccine Distributors
7.5 Infectious Bursal Disease Vaccine Customer Analysis
8 Infectious Bursal Disease Vaccine Market Dynamics
8.1 Infectious Bursal Disease Vaccine Industry Trends
8.2 Infectious Bursal Disease Vaccine Market Drivers
8.3 Infectious Bursal Disease Vaccine Market Challenges
8.4 Infectious Bursal Disease Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Zoetis Inc
Merck
Elanco
Boehringer Ingelheim
Ceva
Qingdao Yibang Biological Engineering Co., Ltd.
Shandong Lvdu Biological Technology Co., Ltd.
Plyco Bioengineering Co., Ltd.
Ruipu Biopharmaceutical Co., Ltd.
Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
List of Tables
 Table 1. Global Infectious Bursal Disease Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Infectious Bursal Disease Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Infectious Bursal Disease Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Infectious Bursal Disease Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Infectious Bursal Disease Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Infectious Bursal Disease Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Infectious Bursal Disease Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Infectious Bursal Disease Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Infectious Bursal Disease Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Infectious Bursal Disease Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Infectious Bursal Disease Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Infectious Bursal Disease Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Infectious Bursal Disease Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Bursal Disease Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Infectious Bursal Disease Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Infectious Bursal Disease Vaccine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Infectious Bursal Disease Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Infectious Bursal Disease Vaccine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Infectious Bursal Disease Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Infectious Bursal Disease Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Infectious Bursal Disease Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Infectious Bursal Disease Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Infectious Bursal Disease Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Infectious Bursal Disease Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Infectious Bursal Disease Vaccine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Infectious Bursal Disease Vaccine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Infectious Bursal Disease Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Infectious Bursal Disease Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Infectious Bursal Disease Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Infectious Bursal Disease Vaccine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Infectious Bursal Disease Vaccine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Infectious Bursal Disease Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Infectious Bursal Disease Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Infectious Bursal Disease Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Infectious Bursal Disease Vaccine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Infectious Bursal Disease Vaccine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Infectious Bursal Disease Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Infectious Bursal Disease Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Infectious Bursal Disease Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Infectious Bursal Disease Vaccine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Infectious Bursal Disease Vaccine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Infectious Bursal Disease Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Infectious Bursal Disease Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Infectious Bursal Disease Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Infectious Bursal Disease Vaccine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Infectious Bursal Disease Vaccine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Infectious Bursal Disease Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Infectious Bursal Disease Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Infectious Bursal Disease Vaccine Sales (K Units) by Type (2020-2025)
 Table 51. Global Infectious Bursal Disease Vaccine Sales (K Units) by Type (2026-2031)
 Table 52. Global Infectious Bursal Disease Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Infectious Bursal Disease Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Infectious Bursal Disease Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Infectious Bursal Disease Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Infectious Bursal Disease Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Infectious Bursal Disease Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Infectious Bursal Disease Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Infectious Bursal Disease Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Infectious Bursal Disease Vaccine Sales (K Units) by Application (2020-2025)
 Table 61. Global Infectious Bursal Disease Vaccine Sales (K Units) by Application (2026-2031)
 Table 62. Global Infectious Bursal Disease Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Infectious Bursal Disease Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Infectious Bursal Disease Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Infectious Bursal Disease Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Infectious Bursal Disease Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Infectious Bursal Disease Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Infectious Bursal Disease Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Infectious Bursal Disease Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. Zoetis Company Information
 Table 71. Zoetis Description and Business Overview
 Table 72. Zoetis Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Zoetis Infectious Bursal Disease Vaccine Product
 Table 74. Zoetis Recent Developments/Updates
 Table 75. Merck Company Information
 Table 76. Merck Description and Business Overview
 Table 77. Merck Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Merck Infectious Bursal Disease Vaccine Product
 Table 79. Merck Recent Developments/Updates
 Table 80. Elanco Company Information
 Table 81. Elanco Description and Business Overview
 Table 82. Elanco Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Elanco Infectious Bursal Disease Vaccine Product
 Table 84. Elanco Recent Developments/Updates
 Table 85. Boehringer Ingelheim Company Information
 Table 86. Boehringer Ingelheim Description and Business Overview
 Table 87. Boehringer Ingelheim Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Boehringer Ingelheim Infectious Bursal Disease Vaccine Product
 Table 89. Boehringer Ingelheim Recent Developments/Updates
 Table 90. Ceva Company Information
 Table 91. Ceva Description and Business Overview
 Table 92. Ceva Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Ceva Infectious Bursal Disease Vaccine Product
 Table 94. Ceva Recent Developments/Updates
 Table 95. Qingdao Yibang Biological Engineering Co., Ltd. Company Information
 Table 96. Qingdao Yibang Biological Engineering Co., Ltd. Description and Business Overview
 Table 97. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Product
 Table 99. Qingdao Yibang Biological Engineering Co., Ltd. Recent Developments/Updates
 Table 100. Shandong Lvdu Biological Technology Co., Ltd. Company Information
 Table 101. Shandong Lvdu Biological Technology Co., Ltd. Description and Business Overview
 Table 102. Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Product
 Table 104. Shandong Lvdu Biological Technology Co., Ltd. Recent Developments/Updates
 Table 105. Plyco Bioengineering Co., Ltd. Company Information
 Table 106. Plyco Bioengineering Co., Ltd. Description and Business Overview
 Table 107. Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Product
 Table 109. Plyco Bioengineering Co., Ltd. Recent Developments/Updates
 Table 110. Ruipu Biopharmaceutical Co., Ltd. Company Information
 Table 111. Ruipu Biopharmaceutical Co., Ltd. Description and Business Overview
 Table 112. Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Product
 Table 114. Ruipu Biopharmaceutical Co., Ltd. Recent Developments/Updates
 Table 115. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Company Information
 Table 116. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Description and Business Overview
 Table 117. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Product
 Table 119. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Infectious Bursal Disease Vaccine Distributors List
 Table 123. Infectious Bursal Disease Vaccine Customers List
 Table 124. Infectious Bursal Disease Vaccine Market Trends
 Table 125. Infectious Bursal Disease Vaccine Market Drivers
 Table 126. Infectious Bursal Disease Vaccine Market Challenges
 Table 127. Infectious Bursal Disease Vaccine Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Infectious Bursal Disease Vaccine
 Figure 2. Global Infectious Bursal Disease Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Infectious Bursal Disease Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Live Product Picture
 Figure 5. Inactivated Product Picture
 Figure 6. Global Infectious Bursal Disease Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Infectious Bursal Disease Vaccine Market Share by Application: 2024 & 2031
 Figure 8. Veterinary Pharmacy
 Figure 9. Online Sale
 Figure 10. Others
 Figure 11. Global Infectious Bursal Disease Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Infectious Bursal Disease Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Infectious Bursal Disease Vaccine Sales (2020-2031) & (K Units)
 Figure 14. Global Infectious Bursal Disease Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 15. Infectious Bursal Disease Vaccine Report Years Considered
 Figure 16. Infectious Bursal Disease Vaccine Sales Share by Manufacturers in 2024
 Figure 17. Global Infectious Bursal Disease Vaccine Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Infectious Bursal Disease Vaccine Players: Market Share by Revenue in Infectious Bursal Disease Vaccine in 2024
 Figure 19. Infectious Bursal Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Infectious Bursal Disease Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Infectious Bursal Disease Vaccine Sales Market Share by Country (2020-2031)
 Figure 22. North America Infectious Bursal Disease Vaccine Revenue Market Share by Country (2020-2031)
 Figure 23. United States Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Infectious Bursal Disease Vaccine Sales Market Share by Country (2020-2031)
 Figure 26. Europe Infectious Bursal Disease Vaccine Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Infectious Bursal Disease Vaccine Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Infectious Bursal Disease Vaccine Revenue Market Share by Region (2020-2031)
 Figure 34. China Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Infectious Bursal Disease Vaccine Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Infectious Bursal Disease Vaccine Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Colombia Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Infectious Bursal Disease Vaccine Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Infectious Bursal Disease Vaccine Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Infectious Bursal Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Infectious Bursal Disease Vaccine by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Infectious Bursal Disease Vaccine by Type (2020-2031)
 Figure 56. Global Infectious Bursal Disease Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Infectious Bursal Disease Vaccine by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Infectious Bursal Disease Vaccine by Application (2020-2031)
 Figure 59. Global Infectious Bursal Disease Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 60. Infectious Bursal Disease Vaccine Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Newcastle Disease Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Research Report 2025
Global Marek s Disease Vaccine Market Research Report 2024
Global Poultry and Livestock Vaccines Market Research Report 2025
Global Coccidiosis Vaccine for Chickens Market Research Report 2024
Global Chicken Newcastle Disease Vaccine Market Research Report 2024
Global Poultry Live Attenuated Vaccine Market Research Report 2024
Global Poultry Bacterial Disease Vaccines Market Research Report 2024
Chicken Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Poultry Vaccines Market Research Report 2025
Poultry Medicine and Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chicken Medicine and Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Poultry Live Vaccines Market Research Report 2025
Global Poultry Viral Disease Vaccines Market Research Report 2024
Vaccines and Drugs for Chicken Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Live type Poultry Vaccine Market Research Report 2025
Global Mycoplasma Galliscepticum Vaccine Market Research Report 2024
Global Avian Pox Vaccine Market Research Report 2024
Global Poultry Coccidiosis Vaccines Market Research Report 2025
Global Live Poultry Vaccine Market Research Report 2025
Duck Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions